National Law Review
6/15/2026
![Short Week for the Senate [Podcast]](https://natlawreview.com/sites/default/files/styles/article_image/public/2026-06/Capital%20Congress%20HandDrawn%20Black%20White%20Washington%20DC%20%281%29_0.jpg.webp?itok=7rABinbh)
Short Week for the Senate [Podcast]
Short summary
The US Senate continues FISA authorization debate this week, with the Healthcare Committee marking up eight bills on June 17th covering organ transplants, stem cell research, breast health education, ALS therapies, medication affordability, and biosimilar access. With only two weeks of joint House-Senate sessions remaining before August recess, legislative capacity for continuing resolutions and fraud prevention initiatives is severely limited.
- •Senate focuses on FISA reauthorization debate and related nomination hearing
- •Eight healthcare bills advancing: organ transplant protections, stem cell research, medication affordability, biosimilar pathways
- •Minimal legislative time before recess constrains September continuing resolution and fraud legislation movement
Generated with AI, which can make mistakes.
Is this a good recommendation for you?



